Map Home
Type / to search with text or keywords
/
keyboard shortcut: Type "/" on your keyboard for a quick search
Search button
Loading...
Loading...
Scroll left
Grants
Citations
H-Index
Patents
News
Books
Scroll right
Collapse sidebar
Data issues & feedback
Adjust height of sidebar
KMap
Grant
Adjust height of sidebar
KMap
Grant
A Dose-Escalation and Expansion Study of the Safety and Pharmacokinetics of XB002 As Single-Agent And Combination Therapy In Subjects With Inoperable Locally Advanced or Metastatic Solid Tumors
Sponsored by Exelixis Pharmaceuticals, Incorporated
Active
$1.6M Funding
3 People
External
Related Topics
cancer,
pharmacokinetics,
drug therapy,
clinical trial,
tumor treatment
People
Linda Garland
Co-Investigator (COI)
Medicine
﹒Professor
Lizeth Evangelista
(CD)
Cancer Center Division
﹒Research Compliance Administrator II
Ruth Ca?amar
(CD)
Cancer Center Division
﹒Research Program Administration Officer III
